8-K
filed February 14, 2023, 6:59 PM ET
ticker BAX
CIK 0000010456
leadership
confidence high
sentiment neutral
materiality 0.55
Baxter announces director retirements, new executives, and cash severance policy
BAXTER INTERNATIONAL INC
- Thomas F. Chen and Albert P.L. Stroucken retiring from board effective April 28, 2023.
- Cathy R. Smith to chair Nominating, Governance & Public Policy; Peter Wilver to chair Audit.
- D. Brent Shafer appointed Lead Independent Director effective April 28, 2023.
- New executives: Heather Knight, Reaz Rasul, Alok Sonig as group presidents effective March 1, 2023.
- Cash severance policy caps new executive benefits at 2.99x base salary plus target bonus without shareholder vote.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Reaz Rasul was appointed as Executive Vice President and Group President, Healthcare Systems and Technologies at BAXTER INTERNATIONAL INC.
- Action
- appointed
- Role
- Executive Vice President and Group President, Healthcare Systems and Technologies
Exact text from the filing
Mr. Reaz Rasul was appointed as the Company’s Executive Vice President and Group President, Healthcare Systems and Technologies.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thomas F. Chen retired as Director at BAXTER INTERNATIONAL INC.
- Action
- retired
- Role
- Director
Exact text from the filing
On February 13, 2023, Mr. Thomas F. Chen notified Baxter International Inc. (the “Company” or “Baxter”) of his decision to retire from the Board of Directors of the Company (the “Board”), effective as of April 28, 2023.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
D. Brent Shafer was appointed as Lead Independent Director at BAXTER INTERNATIONAL INC.
- Action
- appointed
- Role
- Lead Independent Director
Exact text from the filing
the Board also appointed Mr. D. Brent Shafer as the Board’s Lead Independent Director, effective April 28, 2023.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Alok Sonig was appointed as Executive Vice President and Group President, Pharmaceuticals at BAXTER INTERNATIONAL INC.
- Action
- appointed
- Role
- Executive Vice President and Group President, Pharmaceuticals
Exact text from the filing
Mr. Alok Sonig was appointed as the Company’s Executive Vice President and Group President, Pharmaceuticals.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Albert P.L. Stroucken retired as Director at BAXTER INTERNATIONAL INC.
- Action
- retired
- Role
- Director
Exact text from the filing
Mr. Stroucken’s term will expire on April 28, 2023.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Heather Knight was appointed as Executive Vice President and Group President, Medical Products and Therapies at BAXTER INTERNATIONAL INC.
- Action
- appointed
- Role
- Executive Vice President and Group President, Medical Products and Therapies
Exact text from the filing
Ms. Heather Knight was appointed as the Company’s Executive Vice President and Group President, Medical Products and Therapies.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.